90% of people with relapsing-remitting multiple sclerosis will begin to experience fewer relapses after 40 years of age. They will notice gradually worsening fatigue, anxiety, depression, foot drop, stumbles, more bowel and bladder accidents. The disease modifying treatments (DMTs) do a terrific job of reducing new relapses/ lesions but do not restore lost functions. But there are professions, treatments and technologies that have been shown to help achieve meaningful improvements in function. I